Pricing
  1. US-listed companies
  2. Edesa Biotech, Inc.
  3. Financials
  4. Cash from financing

Edesa Biotech, Inc.【EDSA】

Market cap
$35.96M
P/E ratio
SummaryFinancials
Period EndCash from financing (Million USD)YoY (%)
Sep 30, 20241-87.74%
Sep 30, 20235-58.47%
Sep 30, 202212-17.96%
Sep 30, 202114+99.85%
Sep 30, 20207-19.14%
Sep 30, 20189+Infinity%
Sep 30, 20170-100.00%
Sep 30, 20167+6748.85%
Sep 30, 20150

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)